Specialty Pharmacy

Patrick Gleason, PharmD, BCPS, FCCP, director of health outcomes for Prime Therapeutics, explains how split-fill programs can help reduce waste for expensive specialty medications.

Armada Health Care announced today that the AIDS Healthcare Foundation (AHF) has chosen Armada to be its primary purchasing partner.

Roper Industries, Inc announced that it has entered into a definitive agreement to acquire Managed Health Care Associates, Inc (MHA) in a cash transaction valued at $1.0 billion.

Avella Specialty Pharmacy announced today that in 2012 its staff helped patients receive more than $7.2 million in financial assistance.

Results from a recent survey indicate that although payers are more familiar with specialty drugs, nearly half are not satisfied with their specialty pharmacy provider's adherence measurements.

A budget document released by the Obama administration details plans to restrict pay-for-delay agreements and reduce biologic product exclusivity terms.

Differences in patent extension terms in the United States and India have led to a ruling that may affect future drug innovation overseas.

First-line treatment options and new therapies for the treatment of multiple myeloma were recently examined at the 17th International Congress on Hematologic Malignancies in NYC.

The power of Internet search has recently been harnessed to help diagnose obscure diseases and monitor adverse effects of medications used to treat disease.

CVS Caremark today released its annual Insights report, which revealed that the increased availability of generics combined with CVS Caremark's industry-leading generic dispensing rate (GDR) of 77.4% helped reduce spending on traditional medications by 3.6% for the company's commercial clients.

The Specialty Pharmacy Association of America (SPAARx) today announced the launch of its new website.

Managed Health Care Associates, Inc (MHA), a leading health care service company focused on the alternate site health care provider marketplace, announced the completion of its sixth annual Independent Long Term Care Member Study, the results of which were released at the 2013 MHA Business Summit, February 28, 2013 in Las Vegas, Nevada.

In this video from The Academy of Managed Care Pharmacy's 25th Annual Meeting & Expo, Matthias Cheung, PhD, FCSHP, FASHP, from Advanced Rx Consulting, LLC, discusses the circumstances and factors that catalyzed the passage of current legislation and regulatory policies for orphan drugs, rare diseases, and ultra-rare diseases.

The newly released payer-directed resource from Avella details 10 of the most important issues payers should consider when selecting a specialty pharmacy.

Catamaran Corp, a leading provider of pharmacy benefit management (PBM) services and technology, today announced that its specialty brand, BriovaRx, has been awarded Specialty Pharmacy Accreditation from URAC.

A new drug to treat multiple sclerosis has the potential to drive spending increases in the specialty category.

BioPlus Specialty Pharmacy introduces the "2-Hour Patient Acceptance Guarantee" program for fast turn-around from patient referral to acceptance.

Prime Therapeutics' new studies, scheduled to be presented at AMCP, reveal that expected medical savings from the utilization of specialty drugs no longer offset the high cost of these therapies for the treatment of hepatitis C and rheumatoid arthritis.

Armada Health Care (Armada), the nation's largest specialty pharmacy channel management organization, is pleased to announce that it has been awarded Health Call Center, Health Web Site, and Health Content Provider accreditation from URAC.

The Specialty Pharmacy Association of America (SPAARx), the largest national association representing the broad interests of the specialty pharmacy industry, announced that it is launching a national advocacy initiative related to compounding that will be focused on pending federal and state legislation and regulation through agencies such as the FDA.

The court will decide whether "pay-to-delay" arrangements, in which the manufacturer of a branded medication pays another company to keep a generic version off the market, are legal.

The FDA today approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis (MS).

Specialty Pharmacy Times spoke to Glen Stettin, MD, senior vice president, clinical, research and new solutions, about the major findings of the report, the efficiency of patient engagement, and how the proportion of total drug spend for specialty medications will change in the coming years.

Adam J. Fein, PhD, of Pembroke Consulting and Drug Channels, appeared on FOX Business to discuss the recent partnership between Walgreens, Alliance Boots, and AmerisourceBergen.

The National Association of Specialty Pharmacy (NASP) announced Phil Hagerman, chief executive officer, Diplomat Specialty Pharmacy, has joined the NASP Board of Directors.

A study assessing HIV treatment interruption in 14 French subjects suggests that early initiation of antiretroviral therapy may be associated with sustained virological remission.

The Specialty Pharmacy Association of America (SPAARx), the largest national association representing the broad interests of the specialty pharmacy industry, announced it will be advocating against the impending cuts to Medicare reimbursement that are being driven by the sequestration process.

Walgreen Co and Alliance Boots GmbH, a leading international pharmacy-led health and beauty group, today announced that they have entered into an innovative long-term partnership with AmerisourceBergen, one of North America's largest pharmaceutical services companies.